Pharmaceutical care to oncologic patients in a large hospital at Rio de Janeiro
Keywords:
Descritores: Atenção Farmacêutica, acompanhamento farmacoterapêutico, capecitabinaAbstract
Objectives: To evaluate the implementation of Pharmaceutical Care for outpatients under antineoplastic treatment with capecitabine in a large Hospital at Rio de Janeiro.
Methods: The study is an evaluative study. In this perspective, this study can be defined by Hardon et al. (2004) as before-intervention/after-intervention model. The outcome analyzed after-intervention was the measurement of negative clinical outcomes to medicines solved. The patients who was in ambulatorial use of capecitabine have been followed from September 2010 to February 2011. The pharmacotherapy follow-up was based in Dáder´s Method. The project was submitted (CEP CMM / n ˚ HUAP 175/2010) and was approved by the Ethics Committee in Research of Universidade Federal Fluminense (CAAE 3667.0.000.258- 10).
Results: Eighteen women from 39 to 78 years diagnosed with breast cancer, colorectal cancer, duodenal cancer and gastric cancer were followed. Fifty nine NCO related to sixty six DRP were identified. Nineteen interventions were accepted (40%) and the negative clinical outcome have been solved in 12 of these (63% of cases) and twenty interventions were not accepted (43%), and the negative clinical outcome have been solved in five of these (25% of cases).
Conclusion: The study reached the intended goals and has improved the oncology´s assistance in that Hospital.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
